Literature DB >> 32367278

Detection of Group A Beta Hemolytic Streptococci Species, emm, and Exotoxin Genes Isolated from Patients with Tonsillopharyngitis.

Mehzat Altun1, Binnur Mericli Yapıcı2.   

Abstract

Group A Beta Hemolytic Streptococci (GAS) is the most critical human pathogen that leads to tonsillopharyngitis. The aims of this study were to identify GAS isolates and to determine emm typing, the coverage rate of available vaccines, and the distribution of superantigen gene profiles. 15 GAS isolates were isolated from throat cultures of 200 patients with tonsillopharyngitis, who were admitted to Canakkale Health Application and Research Hospital between October 2017 and May 2018. Identification of the isolates was performed by conventional methods and 16S rRNA sequence analysis. emm typing and exotoxin profiling of the isolates were performed by polymerase chain reaction. 7.5% GAS was detected in 200 patients. All the GAS isolates were identified as S. pyogenes. emm typing can be carried out in 13 S. pyogenes isolates. emm89 (33.3%), emm44 (20%), emm6 (13.3%), emm84 (6.7%), emm1 (6.7%), and emm18.1 (6.7%) were found to be six emm types. The coverage rate of S. pyogenes strains for 26-valent vaccine was 61.5% and for the 30-valent vaccine 84.6%. The most common exotoxin was speB (86.7%), followed by speC (60%), speF (33.3%), ssa (26.7%), speA (20%), speM (20%), speJ (13.3%), speL (6.7%), and speI (6.7%). As a result of determining the emm types of S. pyogenes species in Canakkale, it was concluded that the potential of 30-valent vaccine should be considered in Turkey and development of vaccines containing exotoxin types may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32367278      PMCID: PMC7222056          DOI: 10.1007/s00284-020-01994-5

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  29 in total

1.  Molecular characterization of Streptococcus pyogenes group A isolates from a tertiary hospital in Lebanon.

Authors:  Nathalie M Karaky; George F Araj; Sima T Tokajian
Journal:  J Med Microbiol       Date:  2014-06-30       Impact factor: 2.472

2.  Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA.

Authors:  U Edwards; T Rogall; H Blöcker; M Emde; E C Böttger
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

3.  Clinical and molecular epidemiology of beta-hemolytic streptococcal infections in India.

Authors:  Purva Mathur; Nidhi Bhardwaj; Kushal Mathur; Bijayini Behera; Gunjan Gupta; Arti Kapil; Sarman Singh; Mahesh Chandra Misra
Journal:  J Infect Dev Ctries       Date:  2014-03-13       Impact factor: 0.968

4.  New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.

Authors:  James B Dale; Thomas A Penfound; Edna Y Chiang; William J Walton
Journal:  Vaccine       Date:  2011-09-13       Impact factor: 3.641

5.  CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.

Authors:  Jacqueline L Hayworth; Delfina M Mazzuca; Saman Maleki Vareki; Ian Welch; John K McCormick; S M Mansour Haeryfar
Journal:  Immunol Cell Biol       Date:  2011-11-01       Impact factor: 5.126

6.  Antibiotic susceptibility of group A Streptococcus isolated from throat swab culture of school children in Pokhara, Nepal.

Authors:  K R Rijal; N Dhakal; R C Shah; S Timilsina; P Mahato; S Thapa; P Ghimire
Journal:  Nepal Med Coll J       Date:  2009-12

7.  Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans.

Authors:  Emeka I Igwe; Patricia L Shewmaker; Richard R Facklam; Monica M Farley; Chris van Beneden; Bernard Beall
Journal:  FEMS Microbiol Lett       Date:  2003-12-12       Impact factor: 2.742

Review 8.  Group a streptococcal diseases and their global burden.

Authors:  Anna P Ralph; Jonathan R Carapetis
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

Review 10.  Invasive group a streptococcal disease: epidemiology, pathogenesis and management.

Authors:  Andrew C Steer; Theresa Lamagni; Nigel Curtis; Jonathan R Carapetis
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

View more
  1 in total

1.  Assessment of the Relationship between Clinical Manifestation and Pathogenic Potential of Streptococcus pyogenes Strains-Distribution of Genes and Genotypes of Toxins.

Authors:  Tomasz Bogiel; Alicja Domian; Zuzanna Dobrzyńska; Agnieszka Mikucka; Eugenia Gospodarek-Komkowska
Journal:  Biomedicines       Date:  2022-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.